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1. Introduction 
A number of metabolic functions are dependent 
on the interchange between sulfhydryl and disulflde 
groups [l] . Two important mediators of such inter- 
conversions are thioredoxin and glutathione. 
Thioredoxins isolated from E. coli, yeast, liver and 
tumor cells [2-61 have approx. mol. wt 12 000. In 
the reduced form, these proteins have two cysteines 
at the active site. In the presence of disultide com- 
pounds, the active site sulfhydryls of the reduced 
form of thioredoxin are readily oxidized to a disulfide 
bond. The oxidized form of thioredoxin is reduced 
by NADPH and a specific enzyme, thioredoxin 
reductase [7] . In vitro thioredoxin acts as a potent 
reducing agent for both protein and low molecular 
weight disulfides [5,8,9]. Whether it has the same 
function in vivo is not yet clear. 
Glutathione also participates as a reducing agent 
in vitro. It is then converted to a disulfide dimer. The 
oxidized form of glutathione is reduced by NADPH 
and glutathione reductase. The metabolic function of 
glutathione in vivo remains to be established (cf. [lo] ). 
In this study we have used cells from two different 
human mutants in order to study the interplay 
between the glutathione and the thioredoxin systems, 
namely S-oxoprolinuria [ 1 l] and cystinosis [ 121. In 
5oxoprolinuria, the primary metabolic defect is a 
generalized deficiency of glutathione synthetase [ 131. 
This leads to a marked decrease in glutathione concen- 
trations. In cystinosis there is a generalized impair- 
ment of intracellular cystine reduction yielding mas- 
sive lyzosomal storage of cystine [ 141. However, the 
primary metabolic defect has so far not been identified. 
Cells from 5oxoprolinuria cases contained mark- 
edly decreased levels of glutathione synthetase and 
also decreased levels of glutathione. The activity of 
thioredoxin and its reductase were normal indicating 
that the level of glutathione and thioredoxin are 
regulated independently. Also flbroblasts from 
cystinotic patients were found to have normal content 
of glutathione and the thioredoxin system indicating 
that the derangement in the conversion of cystine 
to cysteine in cystinosis is not due to decreased levels 
of either glutathione or thioredoxin in whole cells. 
2. Materials and methods 
2.1. Materials 
Homogeneous thioredoxin was prepared from calf 
liver [5] . Thioredoxin reductase from calf liver of 
better than 50% purity [ 151 was prepared by DEAE- 
cellulose, TEAE-cellulose and Sephadex G-l 00 
chromatography and affinity chromatography on 
2’,5’-ADP-Sepharose. Absorbance and enzymatic 
activities were measured in a Zeiss PMQIII spectro- 
photometer with multiple sample changer and a 
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Servogor 541 recorder. The sources of other materials 
are in [5,8,15] ; the chemicals used were of analytical 
grade and obtained from commercial sources. 
2.2. Preparation of extracts 
gation and the supernatant solution was extracted 
4 times at room temperature with 5 ml diethyl ether 
in order to remove excess dithiothreitol. Glutathione, 
reduced as well as oxidized, was analyzed according 
to the enzymatic method in [ 171. 
Human skin fibroblasts were obtained from 2 
patients with 5-oxoprolinuria [ 1 l] and 3 patients 
with nephropathic cystinosis. The authors are grateful 
to J. D. Schulman for supplying cells from 2 of the 
cystinotic patients. Control fibroblasts were also 
obtained from healthy volunteers. 
Glutathione synthetase was analyzed as in [ 131. 
Thioredoxin was determined as in [5,15] by 
measuring its catalytic activity in the reduction of 
insulin disulfides by excess NADPH and thioredoxin 
reductase. Dithiothreitol activated calf liver thio- 
redoxin was used as standard [ 151. 
The fibroblasts were cultivated in 150 mm Falcon 
petri dishes in Earle’s minimum essential medium 
containing fetal calf serum (IO%), penicillin 
(125 units/ml) and streptomycin (125 pg/ml). The 
cells were harvested in the late log phase of growth. 
After rinsing with cold phosphate-buffered saline 
solution they were detached by scraping with a rubber 
policeman. The cells from 5-10 petri dishes were 
pooled, washed twice with cold phosphate buffered 
saline solution and then immediately frozen in liquid 
nitrogen until analyzed. The frozen cell pellets were 
thawed, suspended in l-2 ml 50 mM Tris-acetate, 
pH 7.5, disrupted by sonication and centrifuged at 
30 000 X g for 30 min. The supernatant solution 
referred to as crude extract was assayed for glutathione 
and glutathione synthetase. 
Thioredoxin reductase was analyzed by Method 2 
as described [ 151 in the presence of 10 /.LM dithio- 
tbreitol-activated calf liver thioredoxin. The activity 
was also measured by the 5,5’-dithio-bis-(2 nitro- 
benzoic acid) assay [ 151 and was expressed as pmol 
thionitrobenzoate formed/min. The two methods gave 
results in good agreement. 
3. Results and discussion 
The concentration of glutathione and the activity 
of ghttathione synthetase, thioredoxin and thioredoxin 
reductase in extracts from tissue cultured fibroblasts 
are shown in table 1. 
For analysis of thioredoxin and thioredoxin 
reductase, the crude cell-free extracts were treated 
with streptomycin sulfate (200 ~1 5% solution/ml) 
and centrifuged at 20 000 X g for 20 min. The precipi- 
tate was discarded and to the residual supernatant 
solution was added ammonium sulfate to give 60% 
saturation. The precipitate was collected and dissolved 
in a small vol. 50 mM Tris-Cl, pH 7.5, 1 mM EDTA 
and incubated with 2 mM dithiothreitol for 30 min at 
t4”C followed by extensive dialysis (2 X 2 h) against 
50 mM Tris-Cl, pH 7.5,2 mM EDTA. 
The levels of glutathione and glutathione synthetase 
activity were significantly lower in 5-oxoprolinuria 
cells compared to control cells. This confirms the 
observation [ 13 ] that the primary enzymatic defect 
in 5-oxoprolinuria, i.e., the ghrtathione synthetase 
mutation is expressed in cultured fibroblasts. Further- 
more, it is apparent that the fibroblast model system 
also exhibits decreased glutathione concentrations as 
a consequence of the enzymatic block. This observa- 
tion indicates that 5-oxoprolinuria fibroblasts in cul- 
ture can be used as a model system for studies of the 
metabolism and biological functions of glutathione. 
Protein was measured as in [ 161 . 
2.3. Enzymatic determinations 
Fibroblasts from 3 cystinotic patients did not differ 
from control cells with respect to the levels of gluta- 
thione and glutathione synthetase. 
Analysis of ghrtathione was performed on duplicate The results also show that the levels of thioredoxin 
0.1 ml ahquots of the crude extracts which were and thioredoxin reductase were very similar in cultured 
incubated at 0°C for 30 min in final vol. 0.5 ml con- fibroblasts from control individuals and from cases of 
taining 50~01 dithiothreitol and 1 ~01 EDTA. The 5-oxoprolinuria and cystinosis. Glutathione deficiency 
volume was then adjusted to 1 ml and a final concen- did not result in a compensatory increase in either 
tration of 5% trichloroacetic acid. After 10 min at thioredoxin or thioredoxin reductase. The defective 
0°C the protein precipitate was removed by centrifu- cystine reduction in cystinosis did not seem to be due 
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Table 1 
Levels of glutathione, glutathione synthetase, thioredoxin and thioredoxin reductase in 
extracts of tissue cultured fibroblasts 
March 1978 
Source of fibroblasts 
Control 5-oxoprolinuria cystinosis 
subjects patients patients 
No. individuals 5 2 3 
Glutathione 1.6 7.9 
(nmol/mg protein) (Zl1.1) (0.8- 2.2) (5.9- 9.8) 
Glutathione synthetase 27 4.0 
(nmol/h/mg protein) (21 -33) (3.4- 4.6) (;: -29) 
Thioredoxin 5.8 
(units/mg protein) (5.3- 6.4) (:::- 6.1) (:::- 6.4) 
Thioredoxin reductase 62 
(munits/mg protein) (50 -84) (:; -56) (;: -65) 
Several separate analyses of each extract and multiple batches of harvested cells were analyzed 
from each individual. Mean values are given and the range is indicated in parenthesis. Thio- 
redoxin activity is expressed as units/mg protein where 1 unit corresponds to the activity of 
1 ng calf liver thioredoxin activated by treatment with dithiothreitol [ 151 .Thioredoxin reduc- 
tase activity is expressed as munits/mg protein where 1 unit is equivalent o the formation of 
1 pmol thionitrobenzoate/min as defined [ 151 
to a general deficiency of either thioredoxin or thio- 
redoxin reductase. The present results were obtained 
with whole cell extracts in vitro and cannot of course 
exclude a subcellular enzyme defect. However, with 
the present small amounts of material this was not 
possible to study. 
Thioredoxin does not possess any enzyme activity 
by itself and the methods for its measurement in 
mammalian cells depend on coupling to disulfide 
reduction in a protein-like insulin. A prerequisite for 
this was the availability of highly purified thioredoxin 
reductase from calf liver, and the observation [8,15] 
that the thioredoxin systems of human and bovine 
organs show a high degree of cross-reactivity. The 
pretreatment of the fibroblast extracts prior to 
analysis served to eliminate glutathione and its reduc- 
tase which will disturb the activity measurements [151. 
This study is a first quantitative measurement of 
the thioredoxin system in human cells. Thioredoxin 
had been shown to be present in human platelets [8] . 
The levels of thioredoxin and thioredoxin reductase 
in the fibroblasts were similar to the corresponding 
levels in calf thymus [ 151. 
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